At 8.2% CAGR, the Middle East & Africa DNA Extraction, Isolation, and Purification Market is Projected to be Worth US$ 166.09 Million by 2030, Says Business Market Insights

According to Business Market Insights research, the Middle East & Africa DNA extraction, isolation, and purification market was valued at US$ 88.41 million in 2022 and is expected to reach US$ 166.09 million by 2030, registering a CAGR of 8.2% from 2022 to 2030. Rising R&D in genomics and emerging applications of extracted and purified DNA are among the critical factors attributed to the Middle East & Africa DNA extraction, isolation, and purification market expansion.

The DNA extraction technique used to isolate DNA from biological samples plays a pivotal role in biotechnology applications, ranging from fundamental research to routine diagnostic and therapeutic decision-making. The extracted, isolated, and purified DNA can be used to study the genetic causes and management of various diseases. DNA extraction, isolation, and purification procedures are commonly used in forensic science studies, genome sequencing, spotting environmental bacteria and viruses, and establishing paternity. Furthermore, ancestry tracking, medical tests, genetic engineering, etc., are a few more application areas of the DNA extraction procedures.

In medicine, DNA can serve as a foundation for diagnosing genetic diseases. It is also helping to derive pharmaceutical products such as hormones and vaccines, and predictive genetic testing for risk assessment and the use of targeted screening and early prevention strategies.

The DNA extracted from patients can be used in the diagnosis of genetic diseases such as sickle cell anemia, cystic fibrosis, Huntington's disease, and Down syndrome. Thus, an increase in patient population worldwide contributes to the demand for the DNA extraction and purification kits, and related products. Additionally, DNA is used in vaccine development and manufacturing (DNA/subunit vaccines). For example, Hepatitis B vaccine is prepared using recombinant DNA technology. Thus, an upsurge in the use of DNA extraction, isolation, and purification processes in various applications drives the growth of market.

On the contrary, high cost of process and need for highly skilled workforces hampers the growth Middle East & Africa DNA extraction, isolation, and purification market.

Based on type, the Middle East & Africa DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held 64.6% share of the Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 57.12 million. It is projected to garner US$ 109.76 million by 2030 to expand at 8.5% CAGR during 2022-2030.

In terms of method, the Middle East & Africa DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held 83.2% share of the Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 73.53 million. It is projected to garner US$ 138.48 million by 2030 to expand at 8.2% CAGR during 2022-2030. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the Middle East & Africa DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held 55.5% share of Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 49.06 million. It is projected to garner US$ 92.94 million by 2030 to expand at 8.3% CAGR during 2022-2030.

By source, the Middle East & Africa DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held 78.4% share of Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 69.28 million. It is projected to garner US$ 130.78 million by 2030 to expand at 8.3% CAGR during 2022-2030. The microbial segment is further subsegmented into bacteria and virus.

Based on application, the Middle East & Africa DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held 41.1% share of the Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 36.37 million. It is projected to garner US$ 69.16 million by 2030 to expand at 8.4% CAGR during 2022-2030. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end user, the Middle East & Africa DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held 51.3% share of Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 45.38 million. It is projected to garner US$ 85.40 million by 2030 to expand at 8.2% CAGR during 2022-2030.

Based on country, the Middle East & Africa DNA extraction, isolation, and purification market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia held 35.7% share of Middle East & Africa DNA extraction, isolation, and purification market in 2022, amassing US$ 31.55 million. It is projected to garner US$ 60.87 million by 2030 to expand at 8.6% CAGR during 2022-2030.

Key players operating in the Middle East & Africa DNA extraction, isolation, and purification market are Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.

- In Aug 2023, Thermo Fisher Scientific launched a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for a wide range of prenatal, postnatal and oncology research applications, the Applied Biosystems CytoScan HD Accel array analyzes the whole human genome and provides improved coverage in more than 5,000 critical genome regions.

- In Jul 2023, QIAGEN launched of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com